Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

We recently published 10 Stocks Crushing While Wall Street Naps. Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the top ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Q2 2025 Earnings Call Transcript August 14, 2025 Cellebrite DI Ltd. beats earnings expectations. Reported EPS is $0.12, ...

InvestingPro Insights CLBT's recent surge to an all-time high is supported by several key metrics and insights from InvestingPro. The company's stock has demonstrated exceptional performance, with a ...

In a remarkable display of market confidence, shares of CLBT have surged to an all-time high, touching a price level of $17.04. This milestone underscores a period of significant growth for the ...

CLBT stock soars to all-time high, reaching $17.04 Company News Published 08/23/2024, 12:32 PM 0 ...

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

CLBT stock soars to all-time high, reaching $18.74 Company News Published 10/18/2024, 09:46 AM 0 ...

We came across a bullish thesis on Cellebrite DI Ltd. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on CLBT. Cellebrite DI Ltd.’s share was trading at $13.98 as ...